Biogen Announces Investor Day on September 21, 2021

Rhea-AI Summary

Biogen (Nasdaq: BIIB) will host an Investor Day on September 21, 2021, focusing on its extensive pipeline in neuroscience and related areas. The event, aimed at investors, will be available via a live webcast at 10:00 a.m. ET and will later be archived. Biogen is recognized for its leadership in treating neurological diseases and holds a diverse portfolio, including multiple sclerosis therapies and groundbreaking treatments for spinal muscular atrophy. More details will follow on their investors' webpage.

Positive

• Investor Day scheduled, providing a platform for engaging with shareholders.
• Focus on a broad pipeline in neuroscience, indicating potential future growth.

Negative

• None.

CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- Biogen Inc.  (Nasdaq: BIIB) announced today that it will hold an Investor Day focused on its broad pipeline across neuroscience and related therapeutic adjacencies. The event will be webcast live on September 21, 2021 at 10:00 a.m. ET. Further details will follow. To access the live webcast, please go to the investors section of Biogen’s website at investors.biogen.com. Following the live webcast, an archived version of the webcast will be available at the same URL.

About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.

We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Contact:
Karen Jewell
Investor Relations
Biogen
781-464-2442

FAQ

What is Biogen's upcoming Investor Day date?

Biogen's Investor Day is scheduled for September 21, 2021.

What will Biogen focus on during its Investor Day?

Biogen will focus on its extensive pipeline across neuroscience and related therapeutic adjacencies.

Where can I watch Biogen's Investor Day webcast?

The webcast can be accessed through the investors section of Biogen's website.

What time will Biogen's Investor Day start?

Biogen's Investor Day will start at 10:00 a.m. ET.

What is Biogen known for in the biotechnology industry?

Biogen is known for its pioneering work in neuroscience and has a leading portfolio for treating multiple sclerosis.